New four-drug cocktail aims to wipe out prostate cancer before surgery
NCT ID NCT07516704
First seen Apr 10, 2026 · Last updated May 10, 2026 · Updated 5 times
Summary
This study tests whether adding two extra drugs to standard hormone therapy can more thoroughly shrink high-risk prostate tumors before they are removed. About 94 men with aggressive prostate cancer will receive the combination and then have surgery to check how much cancer remains. The goal is to see if this approach leads to a complete or near-complete disappearance of cancer in the removed tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.